Trial Profile
A phase II confirmatory study of SMP-862 monotherapy in patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Oct 2018
Price :
$35
*
At a glance
- Drugs Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sumitomo Dainippon Pharma
- 10 Jun 2016 New trial record